Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
NCT07059910 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-07-17
Summary
Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment
Conditions
- Immune Thrombocytopenic Purpura
- Thyroid Disorders
Interventions
- DIAGNOSTIC_TEST
-
Search for thyroid disorders
TSH , FT3 , FT4
- DIAGNOSTIC_TEST
-
Laboratory test
Search for anti thyroid antibodies
- DRUG
-
Steroid and eltrombopage
See when we treat thyroid disorders, will patient respond to steroid or eltrombopage?
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-31
- Primary Completion
- 2026-05-31
- Completion
- 2026-08-15
- FDA Drug
- Yes
More Related Trials
-
Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?
NCT04128358 ·Status: UNKNOWN ·Phase: NA
-
Lymphocyte Counts in Immune Thrombocytopenic Purpura
NCT03244410 ·Status: UNKNOWN
-
" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "
NCT05585944 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura
NCT04311593 ·Status: UNKNOWN
-
Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training
NCT02085993 ·Status: COMPLETED
-
Immune Markers in Pediatric ITP on Second Line Therapy
NCT06093529 ·Status: NOT_YET_RECRUITING
-
Steroid Resistance in Pediatric Immune Thrombocytopenic Purpura
NCT06601543 ·Status: NOT_YET_RECRUITING
-
Eltrombopag in Chronic ITP
NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Meta-analysis - Eltrombopag
NCT01235988 ·Status: COMPLETED
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
NCT07093606 ·Status: RECRUITING ·Phase: NA
-
Immune Thrombocytopenia Management in Adults
NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4
-
Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
NCT00888901 ·Status: COMPLETED ·Phase: PHASE4
-
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
NCT05389007 ·Status: UNKNOWN
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
NCT02859909 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients
NCT03163147 ·Status: UNKNOWN
-
Risk Factors for Thrombosis in Immune Thrombocytopenia
NCT03820960 ·Status: COMPLETED
-
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
NCT07057778 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
NCT01196884 ·Status: UNKNOWN
-
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
NCT00168038 ·Status: COMPLETED ·Phase: PHASE3
-
Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura
NCT05093257 ·Status: UNKNOWN
-
Explore the Relationship Between Platelet Count and Bleeding Score in ITP
NCT06273956 ·Status: RECRUITING
-
Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.
NCT06288932 ·Status: COMPLETED ·Phase: PHASE3